MINOCA: When Men Have a Heart Attack with Normal Arteries

A man has a heart attack. The ambulance arrives. Troponin levels rise in the emergency department. He is taken urgently to the catheterization laboratory for an angiogram, the gold-standard test for obstructive coronary artery disease. The cardiologist looks at the images and sees arteries that are, by conventional definition, clear. No blockage above 50 percent stenosis in any major vessel. Normal coronary anatomy.

And then comes a statement that many men in this situation encounter, in some form, at some point in their subsequent care: “Your arteries look fine.”

This statement is not reassuring. It is incomplete. What it means, accurately interpreted, is that the arteries show no obstructive lesion detectable on angiography. What it does not mean is that no cardiac event occurred, that no myocardial injury happened, or that no diagnosis exists. There is a diagnosis. It is called MINOCA: Myocardial Infarction with Non-Obstructive Coronary Arteries. It is a real myocardial infarction. It has documented causes. It has established diagnostic pathways. It has treatment approaches that differ meaningfully from obstructive coronary artery disease. And it is frequently misunderstood, underdiagnosed, or dismissed in both clinical settings and in the experience of patients who live through it.

This article is for men who have been through that experience, and for men who want to understand what MINOCA is before they or someone they know encounters it.

What MINOCA Is, and What It Is Not

The term MINOCA was formalized in a 2016 position paper from the European Society of Cardiology and further refined in subsequent guidelines. The diagnostic criteria are specific: a confirmed myocardial infarction (defined by elevated troponin consistent with the Universal Definition of Myocardial Infarction), non-obstructive coronary artery disease on angiography (no lesion above 50 percent stenosis in a major epicardial artery), and no other clinically apparent diagnosis at the time of the angiogram that better explains the presentation.

That third criterion matters. MINOCA is not a single disease. It is a working diagnosis that identifies a clinical scenario, elevated troponin plus a non-obstructive angiogram, and requires further investigation to identify the underlying mechanism. The angiogram that shows normal-appearing arteries is not the end of the diagnostic process. It is the beginning of the specific diagnostic process appropriate for MINOCA.

The epidemiology is important context. Across multiple large registries and clinical studies, MINOCA accounts for approximately 5 to 10 percent of all acute myocardial infarctions. While it is statistically more common in women (who account for approximately 50 to 65 percent of MINOCA cases in most series), it occurs with meaningful frequency in men and carries a prognosis that demands it be taken seriously regardless of sex. The one-year mortality in MINOCA is approximately 3 to 4 percent across large registry studies, lower than obstructive MI but substantially higher than the general population, and the rate of recurrent cardiovascular events within five years is significant. 4 / Promising

MINOCA in men is underrepresented in both clinical research and clinical practice guidelines relative to its actual occurrence. Part of this is statistical, since the absolute number of male MINOCA cases is smaller than female. Part of it is a clinical assumption that normal-appearing arteries in men after a troponin rise mean the diagnosis is less serious or less certain. Neither is correct.

The Mechanisms That Cause MINOCA in Men

Because MINOCA is a diagnostic category rather than a single disease, understanding it requires understanding its multiple underlying mechanisms. Different mechanisms have different implications for management and for the risk of recurrence. Several are relevant specifically to men.

Coronary Vasospasm

Coronary vasospasm, also called Prinzmetal’s angina or variant angina in its classic form, involves transient, severe constriction of a coronary artery sufficient to cause complete or near-complete occlusion, myocardial ischemia, and, in some cases, myocardial infarction. The spasm typically occurs spontaneously or in response to triggers including cold, cocaine, nicotine, emotional stress, or certain medications. It resolves spontaneously, leaving an artery that appears entirely normal on a subsequent angiogram. 4 / Promising

Coronary vasospasm is more common in men who smoke, in men with cocaine use, and in men of Asian descent, in whom vasospastic angina has a substantially higher prevalence than in European populations. The electrocardiographic hallmark during an active spasm is transient ST elevation that resolves with resolution of the spasm, a pattern that can be mistaken for an obstructive STEMI until the angiogram is reviewed.

The diagnosis is challenging because the angiogram is typically performed after the spasm has resolved. Your cardiologist may discuss provocative testing with intracoronary acetylcholine or ergonovine to demonstrate vasospasm under controlled conditions, though this is not universally performed and carries procedural considerations that require physician judgment. The clinical history of episodes triggered by cold, nocturnal occurrence, or rapid relief with nitroglycerin is diagnostically useful context.

Plaque Rupture Without Significant Stenosis

This mechanism is less intuitive but well-documented. A coronary artery may contain a plaque that does not narrow the vessel lumen to a degree visible on standard angiography. Plaques at or below 50 percent stenosis are by definition not classified as obstructive, but they are not inert. Thin-cap fibroatheromata, plaques with a lipid-rich necrotic core and a thin fibrous cap, are highly prone to rupture regardless of their luminal impact.

When such a plaque ruptures, it exposes the lipid core to circulating blood, triggering thrombosis. If the thrombus propagates sufficiently, it can cause complete or near-complete vessel occlusion sufficient for myocardial infarction before either spontaneously lysing or being resolved by the body’s own thrombolytic mechanisms. By the time the patient reaches the catheterization laboratory, the thrombus has partially or completely resolved, the artery lumen is restored, and the angiogram shows mild irregularity or a plaque that does not appear hemodynamically significant.

Intravascular imaging modalities, specifically optical coherence tomography (OCT) and intravascular ultrasound (IVUS), can identify plaque characteristics, plaque rupture sites, and residual thrombus that standard angiography cannot resolve. Your cardiologist may recommend intravascular imaging as part of a thorough MINOCA evaluation when plaque rupture without stenosis is suspected. 4 / Promising

Spontaneous Coronary Artery Dissection

Spontaneous coronary artery dissection (SCAD) involves a tear in the coronary artery wall that creates a false lumen. Blood enters the false lumen, compressing the true lumen and reducing or eliminating flow, causing myocardial ischemia or infarction. The outer appearance of the artery on standard angiography may show a haziness or subtle narrowing, but SCAD can be missed entirely on standard angiographic views and is substantially better characterized by OCT imaging.

SCAD is more common in younger women than in men, and in women it is strongly associated with peripartum state, fibromuscular dysplasia, and intense physical exertion. In men, SCAD is rarer but occurs, particularly in association with intense isometric exercise, extreme stress, and connective tissue disorders. Men with SCAD-pattern MINOCA warrant evaluation for underlying arteriopathy including fibromuscular dysplasia, which can be identified on computed tomography angiography of the renal and iliac arteries where FMD is most visible. 3 / Early

Coronary Microvascular Disease

The coronary microvascular system, the small vessels below the resolution of standard angiography, regulates flow delivery to the myocardium. Coronary microvascular disease (CMD) is characterized by abnormal function of these vessels, manifesting as impaired flow reserve, excessive vasoconstriction, or endothelial dysfunction at the microvascular level. The large epicardial arteries appear normal on angiography because they are normal. The dysfunction is occurring in vessels the angiogram cannot see.

CMD can cause myocardial ischemia sufficient to produce troponin elevation, ECG changes, and a clinical presentation indistinguishable from obstructive MI on initial evaluation. In men, CMD is associated with hypertension, diabetes, insulin resistance, and smoking, all of which damage endothelial function preferentially in smaller vessels. The diagnosis requires physiological assessment beyond standard angiography, including measurements of coronary flow reserve (CFR) and index of microvascular resistance (IMR), which can be obtained during catheterization using a pressure-flow wire. 3 / Early

Takotsubo Cardiomyopathy

Takotsubo cardiomyopathy, also called stress cardiomyopathy or apical ballooning syndrome, is a reversible acute cardiomyopathy triggered by intense physical or emotional stress. It produces transient left ventricular dysfunction, typically with apical ballooning and basal hypercontractility, in the context of elevated catecholamines. It can present with troponin elevation, ECG changes, and symptoms identical to an anterior MI.

While Takotsubo is substantially more common in postmenopausal women, it occurs in men. Male Takotsubo cases have several characteristic differences from female cases: men are more likely to have a physical rather than emotional trigger, more likely to have a midventricular or basal variant rather than classic apical pattern, and more likely to have a more complicated acute course including ventricular arrhythmia. In-hospital complications are actually higher in men with Takotsubo than in women. 4 / Promising

The diagnosis is typically established by echocardiography or left ventriculography showing the characteristic wall motion abnormality, with resolution of the dysfunction on follow-up imaging. Cardiac MRI in the acute setting can help distinguish Takotsubo from MI by showing absence of myocardial scarring in the affected territory, whereas obstructive MI leaves late gadolinium enhancement corresponding to infarct territory.

Why the Normal Angiogram Warrants Further Investigation

The angiogram that shows non-obstructive coronary arteries after a confirmed MI is not a reassuring result that closes the diagnostic question. It is a finding that opens a specific set of diagnostic questions. The angiogram has ruled out one cause, obstructive atherosclerosis, and established that the event is attributable to one or more of the mechanisms described above. Determining which mechanism is the task of the post-angiogram investigation.

The clinical consequence of leaving MINOCA uncharacterized is not benign. Without a specific mechanism, management is a best-guess approximation. A man with vasospasm-related MINOCA needs a specific medication approach that reduces vasospasm risk. A man with SCAD-pattern MINOCA needs management that may differ substantially from atherosclerotic MI. A man with CMD needs a diagnostic and management approach focused on microvascular physiology rather than plaque biology. A man with Takotsubo needs reassurance about recovery trajectory but also needs cardiac imaging follow-up to confirm resolution of dysfunction.

The 2021 ESC guidelines for the management of MINOCA explicitly recommend a systematic workup protocol including cardiac MRI, with additional testing guided by findings. The workup identifies a specific mechanism in approximately 85 percent of MINOCA cases when a protocol-driven approach is used, according to data from the CMCS-MINOCA registry and related studies. Leaving that investigation uncompleted means that 85 percent becomes zero.

For men who have experienced a MINOCA event, advocating for a thorough workup is appropriate and supported by current clinical guidelines.

Why Cardiac MRI Is the Pivotal Diagnostic Test

Standard angiography cannot image the myocardium itself. It shows the lumen of the epicardial arteries. It cannot show whether myocardial injury has occurred, where it has occurred, what pattern the injury follows, or whether the injury is characteristic of a specific mechanism.

Cardiac MRI (CMR) can do all of these things. Using late gadolinium enhancement (LGE) sequences, CMR can identify areas of myocardial scarring, characterize the distribution and transmurality of injury, distinguish ischemic from non-ischemic injury patterns, and, in the acute setting, identify myocardial edema and inflammation that indicate the mechanism and timing of injury. 5 / Solid

The LGE distribution pattern provides mechanistically important information. Ischemic injury from coronary occlusion produces subendocardial or transmural LGE that corresponds to the territory of a specific coronary artery, a pattern termed subendocardial or territorial infarction. Myocarditis produces a patchy, mid-wall, epicardial-predominant LGE pattern without coronary territory correspondence. Takotsubo typically produces no LGE in the acutely dysfunctional territory, since the injury is functional rather than structural, with possible transient basal LGE in the phenotype associated with obstruction. SCAD may produce subendocardial or transmural LGE depending on the degree of ischemia. CMD may produce subendocardial LGE in a diffuse or patchy distribution without strict territorial correspondence.

The clinical evidence supporting CMR in MINOCA workup is strong. A systematic review published in JACC: Cardiovascular Imaging, pooling data from over 1,000 MINOCA patients who underwent CMR, found that CMR identified a specific etiology in approximately 87 percent of cases, most commonly MI with infarction pattern, myocarditis, and Takotsubo. The yield is highest when CMR is performed within two weeks of the acute event, while acute edema and inflammation are still detectable.

Men who have had a MINOCA event and received an incomplete workup, or no workup beyond the angiogram, may benefit from a cardiac MRI even weeks or months after the event, as the chronic infarct pattern and LGE distribution may still clarify mechanism.

The Problem of Dismissal

The experience of having a confirmed MI but being told the arteries are normal creates a clinical and psychological situation that can lead to inadequate follow-up. For men, this is compounded by the clinical assumption that MINOCA is primarily a female condition, an assumption that reflects the statistical distribution but leads to underinvestment in male MINOCA cases.

Men with MINOCA report a range of experiences in the medical literature and in qualitative studies. Some are discharged without a clear diagnosis or follow-up plan. Some are advised to reduce stress and return if symptoms recur. Some are started on medications appropriate for obstructive MI without discussion of whether those medications are appropriate for their specific MINOCA mechanism. Some receive a thorough workup and clear follow-up care. The variance in care quality is substantial.

The 2021 ESC MINOCA guidelines, the 2019 AHA Scientific Statement on MINOCA in women (which explicitly notes that its considerations apply to men where evidence permits), and multiple cardiology society position papers all agree that MINOCA warrants a systematic diagnostic workup and mechanism-specific management. These guidelines exist. They are accessible to any treating cardiologist. A patient asking whether their care aligns with current MINOCA guidelines is asking a legitimate clinical question.

For men who feel their MINOCA event has been underinvestigated, a referral to a cardiologist with specific interest in MINOCA, coronary physiology, or microvascular disease is appropriate. Academic medical centers with advanced cardiac imaging capabilities are particularly equipped to perform the complete diagnostic protocol that current guidelines recommend.

What Follow-Up Looks Like

Follow-up after a MINOCA event is mechanism-dependent, which is why establishing the mechanism matters so much. In the absence of a specific mechanism, follow-up is general. With a specific mechanism, it can be targeted.

For all MINOCA patients, follow-up typically includes repeated cardiac imaging to assess ventricular function recovery, particularly for Takotsubo and for MI with significant LGE burden. Echocardiography at 30 days and six months is a common follow-up protocol for Takotsubo to confirm functional recovery.

Modifiable cardiovascular risk factors remain relevant in MINOCA. Hypertension, diabetes, smoking, and dyslipidemia contribute to coronary endothelial dysfunction, microvascular disease, and plaque vulnerability regardless of whether obstructive atherosclerosis was the proximate cause of the acute event. Your cardiologist may recommend aggressive risk factor management as a component of secondary prevention.

For vasospasm-related MINOCA, management typically focuses on avoidance of triggers and discussion of medications that may reduce vasospasm risk. Calcium channel blockers are commonly considered in this context. Your cardiologist may discuss their appropriateness for your specific situation.

For SCAD, conservative management of the acute event is typically preferred when feasible, as percutaneous intervention in SCAD arteries can propagate rather than repair the dissection. Longer-term management focuses on identifying and managing underlying arteriopathies and discussing activity modification during the recovery period.

Psychological recovery after MINOCA is also a legitimate clinical consideration. The combination of a serious cardiac event and an incomplete or confusing explanation of its cause creates a specific form of distress that is well-documented in MINOCA survivors of both sexes. Cardiac rehabilitation programs, which typically include both physical and psychosocial components, are appropriate for MINOCA patients and are associated with reduced anxiety and improved quality of life outcomes. Your physician may recommend a referral to a cardiac rehabilitation program as part of your recovery plan.

Making Sense of a Confusing Diagnosis

MINOCA is not a mystery. It is a characterized clinical entity with established diagnostic pathways and an evidence base that, while still growing, is sufficient to guide thorough evaluation and mechanism-specific management. The experience of having a confirmed cardiac event followed by an angiogram that shows normal-appearing arteries is disorienting. The appropriate clinical response to that disorientation is not reassurance that everything is fine. It is the systematic evaluation that identifies which of the well-established mechanisms caused the event.

For men who have experienced MINOCA and received incomplete evaluation, asking specifically about cardiac MRI, about intravascular imaging if angiographic findings were ambiguous, and about whether the workup followed a systematic protocol is appropriate. For men who are currently navigating this situation, the first question worth asking your cardiologist is: “What is the plan for identifying the specific mechanism of my MI?”

That question opens the diagnostic conversation that MINOCA requires.

Frequently Asked Questions

Q: Can men really have a heart attack with normal-looking arteries? A: Yes. MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries) accounts for roughly 5 to 10 percent of all myocardial infarctions. While it occurs more commonly in women statistically, it occurs with meaningful frequency in men and has the same confirmed biochemical and imaging evidence of myocardial injury as obstructive MI. The normal angiogram means no major blockage was found, not that no cardiac event occurred.

Q: What is the most important test to have after a MINOCA diagnosis? A: Cardiac MRI is considered the pivotal diagnostic test after a MINOCA event. It can identify myocardial injury patterns, distinguish ischemic from non-ischemic causes, detect myocarditis, characterize Takotsubo, and provide information that guides mechanism-specific management. Current guidelines recommend CMR as part of a systematic MINOCA workup. Discuss with your cardiologist whether and when it is appropriate in your case.

Q: Is MINOCA less serious than a regular heart attack? A: MINOCA carries a lower short-term mortality than obstructive MI in most series, but it is not a benign diagnosis. Registry data show approximately 3 to 4 percent one-year mortality and significant rates of recurrent cardiovascular events within five years. The specific prognosis depends substantially on the underlying mechanism, which is one reason identifying that mechanism matters for appropriate follow-up and management.

Q: What causes coronary vasospasm in men specifically? A: In men, coronary vasospasm is associated with smoking, cocaine and stimulant use, intense cold exposure, and in some cases certain medications. It is more prevalent in men of Asian descent than in men of European descent. The vasospasm itself causes transient complete or near-complete coronary occlusion that resolves before the angiogram, leaving arteries that appear normal. Provocative testing during catheterization can demonstrate vasospasm under controlled conditions if your cardiologist considers it appropriate.

Q: I had a MINOCA event and was told to follow up with my regular doctor. Is that sufficient? A: Current ESC and AHA guidelines recommend a systematic specialist workup for MINOCA, including cardiac MRI and, in many cases, evaluation of coronary physiology and microvascular function. If your follow-up plan consists only of primary care visits without cardiology involvement, cardiologist referral is warranted. A cardiologist with interest in coronary physiology, microvascular disease, or advanced cardiac imaging is particularly well-positioned to complete the workup your situation requires. Discuss this directly with your physician.

The Signal Check is fifteen questions mapping the male cardiovascular risk pattern, including the physiological domains most commonly missed in standard screenings. It produces a specific starting point for your next clinical conversation.